Wed. Oct 16th, 2019

My Health Reporter

Leading Health News Website

Sickle Cell Disease Treatment Market Size Industry Analysis, Share, Growth, Trends and Forecast 2017-2025

3 min read

A detailed study on ‘Sickle Cell Disease Treatment Market’, formulated by Persistence Market Research, offers an in-depth analysis of the key factors impacting the current business scenario across key regions. In-depth information pertaining to the industry’s size, share, application, and statistics are also summed up in the report to present a comprehensive outlook on the market. In addition, this report also offers an accurate competitive analysis illustrating the status of market forerunners and their unique portfolios, while including their expansion strategies and portfolio.

Global sickle cell disease treatment market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing adoption of therapies, growing awareness regarding the sickle cell disease treatment in MEA region. “Sickle Cell Disease Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)” is the new report published by Persistence Market Research for the projected period of 8-years, i.e. 2017-2025.

Request For Sample@ https://www.persistencemarketresearch.com/samples/16099

According to this report, the global sickle cell disease treatment market is projected to expand at a CAGR of 6.0 % in terms of value during the forecast period to reach US$ 584.0 Mn by 2025. There is an increased opportunity of the development of the global sickle cell disease treatment market due to drug approvals and drugs in the pipeline which are expected to enter the market in the coming five years.

Global Sickle Cell Disease Treatment Market: Drivers

  • Increasing discretionary research funding for Sickle cell anaemia in developed countries
  • Governments focus on creating awareness on sickle cell anemia cure
  • Aging population in developed economies and rising affluence in emerging markets to boost healthcare spending
  • Demand for drug therapy in combination with surgeries and blood transfusion
  • Changes in lifestyle to increase the probability of genomic mutations
  • Increasing penetration of FDA approved drugs in the market
  • Various key players in the sickle cell disease treatment market are signing partnerships and licensing deals to share the research and development platform
  • Reduction of overall diagnosis cost for sickle cell diseases

Global Sickle Cell Disease Treatment Market: Forecast by Drug Type

On the basis of drug type, the global sickle cell disease treatment market is segmented into hydroxyurea, antibiotics, pain-relieving medications, and Others. The hydroxyurea segment is likely to be accounted for 38.7 % market revenue share in 2017, which is expected to increase to 35.7% by 2025 end. This drug type is expected to account for a high revenue contribution in the global sickle cell disease treatment market as compared to other drug types over the forecast period. Hydroxyurea product is expected to be the second attractive drug type segment in sickle cell disease treatment market, with market attractiveness index of 1.2.

Global Sickle Cell Disease Treatment Market: Forecast by Disease Type

On the basis of disease type, the global sickle cell disease treatment market is segmented into sickle cell anemia, sickle hemoglobin C disease, and sickle beta thalassemia. Sickle cell anemia is expected to be the most lucrative among all disease type segment of sickle cell disease treatment market, with attractiveness index of 1.8. Sickle Beta Thalassemia is expected to be the second attractive drug type segment in sickle cell disease treatment market, with market attractiveness index of 0.7.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/16099

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Market View Point
3.1. Opportunity Analysis
3.2. Global Market Drivers
3.2.1. Macroeconomic Drivers
3.2.2. Demand-side Drivers
3.2.3. Supply-side Drivers
3.3. Global Market Restraints
3.4. Global Market Trends
3.5. Epidemiology data of Sickle cell Disease, 2015
3.6. Epidemiology data of Sickle cell Disease < 5 years, 2015
3.7. Product Pipeline Analysis

4. North America Sickle Cell Disease Treatment Market Analysis 2012–2016 and Forecast 2017–2025
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) and Forecast By Country, 2017–2025
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
4.5.1. Hydroxyurea
4.5.2. Antibiotics
4.5.3. Pain-relieving Medications
4.5.4. Others
4.6. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
4.6.1. Hydroxyurea
4.6.2. Antibiotics
4.6.3. Pain-relieving Medications
4.6.4. Others
4.7. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012–2016
4.7.1. Sickle cell anemia
4.7.2. Sickle hemoglobin C disease
4.7.3. Sickle beta thalassemia
4.7.4. Others
4.8. Market Size (US$ Mn) and Forecast, By Disease Type, 2017–2025
4.8.1. Sickle cell anemia
4.8.2. Sickle hemoglobin C disease
4.8.3. Sickle beta thalassemia
4.8.4. Others
4.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
4.9.1. Hospital Pharmacies
4.9.2. Retail Pharmacies
4.9.3. Online Pharmacies

Leave a Reply

Your email address will not be published. Required fields are marked *